Clinical Diagnostics Automation: Market Research Report

Date: January 5, 2014
Pages: 275
Price:
US$ 4,950.00
Publisher: Global Industry Analysts, Inc
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C2A9CAB7FDEEN
Leaflet:

Download PDF Leaflet

Clinical Diagnostics Automation: Market Research Report
This report analyzes the worldwide markets for Clinical Diagnostics Automation in US$ Thousands by the following Product Segments: Automated Analyzers, Stand-alone Automation, and Total Lab Automation. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 57 companies including many key and niche players such as -
  • Abaxis, Inc.
  • Abbott Diagnostics, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • bioMérieux SA
I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Market Segmentation
Automated Analyzers
Stand-Alone Automation
Total Laboratory Automation

II. EXECUTIVE SUMMARY

1.INDUSTRY OVERVIEW

Changing Attitude towards Automation in Clinical Diagnostic Laboratories
Primary Factors Encouraging Laboratories to Embrace Automation – In A Nutshell
Automation – A Panacea to the Laboratories’ Plight
The Road Ahead for Clinical Diagnostics Automation
Drivers, Trends and Challenges in the Global Lab Automation Market - At a Glance
Growth Drivers
Trends
Issues and Challenges
Despite Challenges, Emerging Markets Provide Growth Opportunities
Developed Nations: Cost Pressures Necessitate New Strategies
Regulatory Environment
Competition

Table 1. Leading Players in the Global Laboratory Automation Market (2011): Percentage Breakdown of Value Sales for Danaher, Eppendorf, Perkin Elmer, Tecan, Thermo and Others (includes corresponding Graph/Chart)

2.MARKET TRENDS, DRIVERS AND ISSUES

Need for High-Quality Healthcare Drives Demand for Clinical Diagnostics Automation
Rising Investments in Biotechnology – A Key Growth Driver
Clinical Diagnostics Automation - A Vital Tool in Patient Treatment Management
Need to Reduce Turnaround Times – A Major Growth Factor
Increasing Healthcare Spending in Emerging Markets – Opportunity for growth

Table 2. Healthcare Spending as % of GDP in Select Countries (2011) (includes corresponding Graph/Chart)

Healthcare Needs of Aging Population – An Important Opportunity Indicator

Table 3. Elderly Population (60+ Years) as a Percentage of Total Population (2012 & 2050) (includes corresponding Graph/Chart)
Table 4. Global Aging Population (60+) and their Proportion of Total Population (2012 & 2050) (includes corresponding Graph/Chart)

Rapid Detection of Infectious Diseases: Enhancing Need for Clinical Laboratory Automation Equipment

Table 5. Reported Cases of Major Infectious by Geographic Region (2011)

Rising Incidence of Cancer to Propels Demand for Clinical Diagnostics Automation

Table 6. World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported in Thousands for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
Table 7. New Cancer Cases in the World by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
Table 8. World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths in Thousands for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
Table 9. Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal and Liver Cancers (includes corresponding Graph/Chart)
Table 10. Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus and Liver Cancers (includes corresponding Graph/Chart)
Table 11. Global Cancer Mortality in Men for Select Cancers (2012): Number of Deaths in Thousands for Lung & Bronchus, Liver, Colorectal and Prostate Cancers (includes corresponding Graph/Chart)
Table 12. Global Cancer Mortality in Women for Select Cancers (2012): Number of Deaths in Thousands for Breast, Lung & Bronchus, Colorectal and Liver Cancer Prone Sites based on Age (includes corresponding Graph/Chart)

Cancer Prone Sites based on Age
End-User and Technology-Led Aspects Drive Demand for Automation
Automation – The Prime Solution to Enhance Laboratory Efficiency
Total Laboratory Automation – Only Good Enough for Large Hospitals
Large Hospitals See Good Return on Investments by TLA
Issues Continue to Plague Large Scale Automation Solutions
Bright Prospects Ahead for TLA
Modular Automation Surges Ahead of TLA in Adoption
Rising Demand for Automated Hematology Analyzers
Technological Advancements and Rising Awareness Levels Drive Growth in the Global Biochemistry Analyzers Market
Demand for POC Testing Rises
Automation Liberates Patients from Risk of Pre-analytical Diagnostic Errors
Blood Gas Analyzers – A Potential Solution to Reduce Time Lag Between Testing and Results
Point-of-care Testing – A Revolution in the Blood Gas and Electrolyte Analyzers Market
Automated Multiplexing Technology: Major Role in Clinical Diagnostics Automation
Multiplex Testing for Herpes Simplex Virus Type 1 and
Microbiology Labs: Growing Need for Automation
Automation to Provide Impetus to New Businesses
Internet Revolutionizes Laboratory Diagnostics
System Compatibility: A Key Requirement
Labor Shortage: A Key Challenge in the Clinical Lab Automation Market
Clinical Diagnostics Automation to Insulate Effects of Tightening Labor Market
Bar Code Technology Continues to Gain Adoption in Clinical Settings
Barcoding Eases Specimen and Consumable Identification
Bar Code Labeling Protects Patient Safety
Benefits of Barcoding to Medical Device Manufacturers
Laboratory Information System – A Key Aspect of Clinical Diagnostics Automation
Operational Concerns Associated with LIS

3.CLINICAL DIAGNOSTICS AUTOMATION – AN OVERVIEW

Laboratory Automation: Order of the Day
Benefits of Laboratory Automation
Introduction to Clinical Diagnostics Automation
Evolution of Clinical Diagnostics Automation
Components of Laboratory Automation System
Typical Diagnostic Laboratory Structure
Laboratory Control and Information System
Sample Storage
Sample Preparation
Transportation
Analysis
Clinical Diagnostics Automation by Market Segment
Automated Analyzers
Stand-Alone Automation
Total Laboratory Automation (TLA)
Limitations of TLA Systems
Modular Automation: Emerging Alternative
Total Laboratory Automation (TLA) Vs. Modular Laboratory Automation
Decentralized Testing Gains Importance
Advantages of POC Testing Over Centralized Laboratory Testing
Cost Analysis of POC Testing Vs. Laboratory Testing
Cost Savings through Space Savings
Major Components of Multi-Step Automation Process
Consolidation of Workstation
Information Management

4.PRODUCT INTRODUCTIONS/INNOVATIONS

Hamilton Unveils LabElite Range of Automated Benchtop Devices
Axiom Veterinary Laboratories Rolled out MiLab Range
Transasia Unveils Five New Automated Lab Instruments
Transasia Bio-Medicals Unveils Sysmex XN Series Differential Haematology Analyser
Immunetics Launches BacTx Analyzer for Use with BacTx Rapid Test
SIEMENS Launches VersaCell X3 Solution
Roche Launches cobas 8100 Automated Workflow Series
Roche Launches cobas® 6800 and cobas® 8800 Systems
Abbott Launches ACCELERATOR® a3600 Next Generation Automation Solution
Beckman Coulter Launches UniCel DxH 600 Benchtop Hematology Analyzer
Microscan Unveiled Auto ID and Machine Vision Technologies Line
Siemens Unveils Sysmex® CS-5100 System
Siemens Launches Aptio™ Automation
Roche Launches cobas p 312 Pre-Analytical System
Randox Unveils RX Daytona Compact Clinical Chemistry Analyser

5.RECENT INDUSTRY ACTIVITY

Carlyle Group to Acquire Ortho-Clinical Diagnostics
Singulex Partners with Tecan for Commercial Development of Ultrasensitive Sgx Clarity™ System
Roche and Hitachi Renew Development and Manufacturing Contract
Sysmex America Inks Distribution Agreement with Henry Schein
ERBA Diagnostics Receives FDA Approval for XL200 Clinical Chemistry Analyzer
Abaxis Receives Health Canada Class III Clearance for Piccolo Xpress®
NorDx to Acquire Sysmex® XN-Series Automated Hematology Analyzers
Francisco Partners Takes over McKesson’s Hospital Automation Unit
Cerner Takes over Labotix Automation
Bio-Rad Enters into Development Agreement with Inpeco
CryoXtract™ Inks Distribution Agreement with Bio-Strategy Ltd
CML HealthCare Enters into Vendor Supply Agreement with Sysmex Canada
BD Completes Takeover of KIESTRA Lab Automation BV
Sysmex America Receives FDA Clearance of XN-Series Hematology Analyzers Products
IRIS International Inked Distribution Agreement with Alifax

6.FOCUS ON SELECT GLOBAL PLAYERS

Abaxis, Inc. (US)
Abbott Diagnostics, Inc. (US)
Beckman Coulter, Inc. (US)
Becton, Dickinson and Company (US)
bioMérieux SA (France)
Bio-Rad Laboratories, Inc. (US)
Diagnostica Stago (France)
Eppendorf AG (Germany)
F. Hoffmann-La Roche Ltd. (Switzerland)
HORIBA ABX S.A.S. (France)
Hudson Robotics, Inc. (US)
Ortho Clinical Diagnostics, Inc. (US)
PerkinElmer Inc. (US)
QIAGEN NV (The Netherlands)
Siemens Healthcare Diagnostics, Inc. (US)
Sysmex America, Inc. (US)
Tecan Group Ltd. (Switzerland)
The ELITechGroup SAS (France)
Thermo Fisher Scientific, Inc. (US)

7.GLOBAL MARKET PERSPECTIVE

Table 13. World Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 14. World Historic Review for Clinical Diagnostics Automation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 15. World 15-Year Perspective for Clinical Diagnostics Automation by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 16. World Recent Past, Current and Future Analysis for Automated Analyzers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 17. World Historic Review for Automated Analyzers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 18. World 15-Year Perspective for Automated Analyzers by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 19. World Recent Past, Current and Future Analysis for Total Lab Automation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 20. World Historic Review for Total Lab Automation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 21. World 15-Year Perspective for Total Lab Automation by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 22. World Recent Past, Current and Future Analysis for Stand-alone Automation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 23. World Historic Review for Stand-alone Automation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 24. World 15-Year Perspective for Stand-alone Automation by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1.THE UNITED STATES

A. Market Analysis
Current and Future Analysis
Healthcare Industry Dynamics Augur Well for Lab Automation

Table 25. Healthcare Spending as a % of GDP (includes corresponding Graph/Chart)

Growing Complexity of Tests Necessitates Automation of Lab Operations
Increasing Pressure on Healthcare Organizations Fuels Adoption of Laboratory Automation Systems
Shortage of Qualified Lab Workforce: A Major Growth Driver

Table 26. Overall Vacancy Rates (%) by Laboratory Departments for the Year 2012 (includes corresponding Graph/Chart)

Rising Diagnostic Needs of Aging Population

Table 27. North American Elderly Population by Age Group (1975-2050) (includes corresponding Graph/Chart)
Table 28. US Population Breakdown by Age Group (2012) (includes corresponding Graph/Chart)

TLA Systems: Improving Quality & Turnaround Times
Modular Automation Scores over Total Laboratory Automation Approach
Automation Ensures Error-Free and Faster Test Results
Regulations Dictate Technological Changes in Laboratories
FDA Regulations and Classification of Devices in Clinical Laboratory Automation
Product launches
Strategic corporate developments
Key Players
B. Market Analytics

Table 29. US Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 30. US Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 31. US 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

2.CANADA

A. Market Analysis
Outlook
Strategic Corporate Development
B. Market Analytics

Table 32. Canadian Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 33. Canadian Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 34. Canadian 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

3.JAPAN

Market Analysis

Table 35. Japanese Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 36. Japanese Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 37. Japanese 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4.EUROPE

A. Market Analysis
European Clinical Diagnostics Automation Market: A Prelude
Clinical Diagnostics Market: An Overview

Table 38. Diagnostics Market in Europe (2012): Percentage Share Breakdown of Revenues by Medical Imaging, Laboratory Testing, and Anatomic Pathology (includes corresponding Graph/Chart)

Debt Crisis in Europe Affects Healthcare Industry
Increasing Testing Needs of the Elderly: Business Case for Lab Automation

Table 39. Population Breakup by Age Group for Select European Countries: 2012 (As a % of Total Population) (includes corresponding Graph/Chart)

Manufacturers Face Significant Challenges
Automation Supports Growth in West European IVD Market
B. Market Analytics

Table 40. European Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 41. European Historic Review for Clinical Diagnostics Automation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 42. European 15-Year Perspective for Clinical Diagnostics Automation by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 43. European Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 44. European Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 45. European 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4A.FRANCE

A. Market Analysis
Key Players
B. Market Analytics

Table 46. French Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 47. French Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 48. French 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4B.GERMANY

A. Market Analysis
Product Launch
B. Market Analytics

Table 49. German Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 50. German Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 51. German 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4C.ITALY

Market Analysis

Table 52. Italian Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 53. Italian Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 54. Italian 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4D.THE UNITED KINGDOM

A. Market Analysis
Product launch
B. Market Analytics

Table 55. UK Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 56. UK Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 57. UK 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4E.SPAIN

Market Analysis

Table 58. Spanish Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 59. Spanish Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 60. Spanish 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4F.RUSSIA

Market Analysis

Table 61. Russian Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 62. Russian Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 63. Russian 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4G.REST OF EUROPE

A. Market Analysis
Product Launches
Strategic corporate development
Key Players
B. Market Analytics

Table 64. Rest of Europe Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 65. Rest of Europe Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 66. Rest of Europe 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5.ASIA-PACIFIC

A. Market Analysis
Outlook
Healthcare Spending in Asia-Pacific: On the Rise
B. Market Analytics

Table 67. Asia-Pacific Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 68. Asia-Pacific Historic Review for Clinical Diagnostics Automation by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 69. Asia-Pacific 15-Year Perspective for Clinical Diagnostics Automation by Geographic Region - Percentage Breakdown of Revenues for China, India and Rest of Asia-Pacific Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 70. Asia-Pacific Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 71. Asia-Pacific Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 72. Asia-Pacific 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5A.CHINA

A. Market Analysis
Outlook
Healthcare Reforms: Opportunities for Clinical Labs Market
B. Market Analytics

Table 73. Chinese Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 74. Chinese Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 75. Chinese 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5B.INDIA

A. Market Analysis
Automation of Clinical Laboratories on the Rise
Challenges Abound in the Indian Clinical Diagnostics Labs Market
Private Enterprises Encourage Changes in Diagnostics Sector
Indian Blood Gas and Electrolyte Analyzers Market

Table 76. Indian Blood Gas and Electrolyte Analyzers and Reagents (2013): Percentage Breakdown of Value and Volume Sales by Segment (includes corresponding Graph/Chart)

A List of Key Vendors in the Indian Blood Gas and Electrolyte Analyzers and Reagents Market
Product launches
B. Market Analytics

Table 77. Indian Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 78. Indian Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 79. Indian 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5C.REST OF ASIA-PACIFIC

A. Market Analysis
Outlook
Singapore
B. Market Analytics

Table 80. Rest of Asia-Pacific Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 81. Rest of Asia-Pacific Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 82. Rest of Asia-Pacific 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

6.LATIN AMERICA

Market Analysis

Table 83. Latin American Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 84. Latin American Historic Review for Clinical Diagnostics Automation by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 85. Latin American 15-Year Perspective for Clinical Diagnostics Automation by Geographic Region - Percentage Breakdown of Revenues for Brazil and Rest of Latin America Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 86. Latin American Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 87. Latin American Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 88. Latin American 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

6A.BRAZIL

A. Market Analysis
Outlook
Clinical Diagnostics Automation Market Poised to Grow

Table 89. Brazilian Clinical Diagnostics Automation Market (2011): Market Share Breakdown by Leading Companies - Abbott Diagnostics, Roche Diagnostics, Siemens Healthcare, and Others (includes corresponding Graph/Chart)

B. Market Analytics

Table 90. Brazilian Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 91. Brazilian Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 92. Brazilian 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

6B.REST OF LATIN AMERICA

Market Analysis

Table 93. Rest of Latin American Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 94. Rest of Latin American Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 95. Rest of Latin American 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

7.REST OF WORLD

A. Market Analysis
Outlook
South Africa
Major Challenges Impeding Laboratory Automation in Africa
B. Market Analytics

Table 96. Rest of World Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 97. Rest of World Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 98. Rest of World 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 57 (including Divisions/Subsidiaries - 62)
The United States (37)
Canada (2)
Japan (1)
Europe (19)
  France (3)
  Germany (3)
  The United Kingdom (6)
  Italy (1)
  Rest of Europe (6)
Asia-Pacific (Excluding Japan) (3)
Skip to top


Ask Your Question

Clinical Diagnostics Automation: Market Research Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: